{
    "nctId": "NCT03401359",
    "briefTitle": "The Resistance and Immune Response to Palbociclib in Breast Cancer",
    "officialTitle": "Prospective Longitudinal Biomarker Study of Acquired Resistance and Immune Response to Palbociclib in Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer Stage IV",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "N/A",
    "primaryPurpose": "BASIC_SCIENCE",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Biomarker of palbociclib in metastatic breast cancer",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Hormone receptor positive, metastatic breast cancer\n* Treated by palbociclib with endocrine therapy\n\nExclusion Criteria:\n\n* Hormone receptor negative breast cancer\n* Treated without palbociclib\n* Refuse and withdrawal to this study",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}